Post-earnings recap
Reported
Wed, Feb 18, 2026
EPS actual
$2.39
EPS est.
$2.33
EPS surprise
+2.49%
1-day move
-0.33%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Charles River Laboratories reported an EPS of $2.39, exceeding expectations slightly. However, the stock reacted negatively, declining by 0.33%. The lack of revenue figures and guidance may have contributed to investor uncertainty, impacting the stock price.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.39 | N/A | +2.49% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results. Therefore, management's messaging is unclear.